ROB HILL
CEO
TAE LIFE SCIENCES
WHY: Took over in 2023 company aiming to use technology first developed at nuclear reactors to cure cancer in particularly dangerous areas like the brain. Valuation has risen.
IN THE NEWS: Partnering with the University of Wisconsin–Madison to launch the first accelerator-based boron neutron capture therapy center in the U.S.
NOTABLE: Has raised more than $100M from outside investors to date.
QUOTABLE: “I’ve made it my life’s work to cure cancer. The thing I realized early in life is that cancer touches all of us. There’s no avoiding that reality. One in three people alive will get cancer at some point in their lives.”
